Cargando…

SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy

Introduction: Immune related endocrine adverse effects (IReAs) caused by checkpoint inhibitors (CI) used in the treatment of advanced cancers are rare and often under recognized, but they can be potentially life-threatening. Case: A 69 y/o male with stage 4 metastatic colon cancer was evaluated 10 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Tanvi, Sharma, Meeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552853/
http://dx.doi.org/10.1210/js.2019-SUN-413